NetraMark Holdings Inc.

CNSX:AIAI Stock Report

Market Cap: CA$70.9m

NetraMark Holdings Management

Management criteria checks 2/4

NetraMark Holdings' CEO is George Achilleos, appointed in Feb 2022, has a tenure of 2.83 years. total yearly compensation is CA$265.00K, comprised of 90.6% salary and 9.4% bonuses, including company stock and options. directly owns 1.82% of the company’s shares, worth CA$1.29M. The average tenure of the management team and the board of directors is 2.6 years and 2.5 years respectively.

Key information

George Achilleos

Chief executive officer

CA$265.0k

Total compensation

CEO salary percentage90.6%
CEO tenure2.8yrs
CEO ownership1.8%
Management average tenure2.6yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Nurosene Health (CSE:MEND) Is In A Good Position To Deliver On Growth Plans

Sep 08
Nurosene Health (CSE:MEND) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has George Achilleos's remuneration changed compared to NetraMark Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CA$11m

Mar 31 2024n/an/a

-CA$12m

Dec 31 2023n/an/a

-CA$13m

Sep 30 2023CA$265kCA$240k

-CA$14m

Jun 30 2023n/an/a

-CA$13m

Mar 31 2023n/an/a

-CA$12m

Dec 31 2022n/an/a

-CA$13m

Sep 30 2022CA$220kCA$220k

-CA$13m

Jun 30 2022n/an/a

-CA$9m

Mar 31 2022n/an/a

-CA$10m

Dec 31 2021n/an/a

-CA$8m

Sep 30 2021CA$32kCA$32k

-CA$5m

Compensation vs Market: George's total compensation ($USD184.41K) is about average for companies of similar size in the Canadian market ($USD164.16K).

Compensation vs Earnings: George's compensation has increased whilst the company is unprofitable.

CEO

George Achilleos

2.8yrs

Tenure

CA$265,000

Compensation

Mr. George Achilleos serves as Chief Executive Officer of NetraMark Holdings Inc. (formerly known as Nurosene Health Inc.) from February 17, 2022 and serves as its Director since March 28, 2024 and was its...

Leadership Team

NamePositionTenureCompensationOwnership
George Achilleos
CEO & Director2.8yrsCA$265.00k1.82%
CA$ 1.3m
Josh Spiegel
President2.1yrsCA$403.86k3.9%
CA$ 2.8m
Daniel Gallucci
Founder4yrsCA$32.00kno data
Joseph Geraci
Founder3.2yrsCA$200.00k6.14%
CA$ 4.4m
Swapan Kakumanu
Chief Financial Officer2.4yrsCA$78.00kno data
Jaime Hackett
Vice President of Marketing1.9yrsno datano data
Luca Pani
Chief Innovation & Regulatory Officer and Chief Medical Advisor3.5yrsno data1.45%
CA$ 1.0m
Kaveh Kavoosi
Head of Progressive Medicineno datano datano data
Larry Alphs
Chief Medical Officer & Member of Advisory Board1.1yrsno datano data
Angelico Carta
Chief Strategy Officerno datano datano data
Mark Smithyes
President of NetraMark3.1yrsno datano data

2.6yrs

Average Tenure

54yo

Average Age

Experienced Management: AIAI's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
George Achilleos
CEO & Directorless than a yearCA$265.00k1.82%
CA$ 1.3m
Daniel Gallucci
Founder3.8yrsCA$32.00kno data
Joseph Geraci
Founder2.5yrsCA$200.00k6.14%
CA$ 4.4m
Larry Alphs
Chief Medical Officer & Member of Advisory Board1.8yrsno datano data
Chuck McBride
Member of Advisory Boardno datano datano data
Kevin Taylor
Independent Chairman of the Board3.1yrsno data1.24%
CA$ 880.4k
William Travis
Member of Advisory Boardno datano datano data
Andrew Parks
Independent Director3.8yrsno data0.78%
CA$ 552.7k
Peter Carlisle
Member of Advisory Boardno datano datano data
Amal Wolfe
Member of Advisory Boardno datano datano data
Dean Sebastian
Member of Advisory Boardno datano datano data
Dhananja Jayalath
Member of Advisory Board2.3yrsno datano data

2.5yrs

Average Tenure

Experienced Board: AIAI's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NetraMark Holdings Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution